Ann: Botanix Antimicrobial Platform Addresses Global Threat, page-47

From the announcement, I don't think this is misleading

Professor of Microbiology at the Monash Biomedicine Discovery Institute and President Australian Society of Microbiology, Dena Lyra, commented:“Often the global threat of C. difficile infection is overlooked. In the United States alone, C. difficile is responsible for nearly 500,000 infections and 30,000 deaths annually - at an estimated US$5.2 billion in health care costs1. Because of this, the US 1 Zhang et al Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States Clinical Infectious Diseases, Volume 66, Issue 9, 1 May 2018, Pages 1326–1332 2 Centers for Disease Control and Prevention recently classified infections with C. difficile among the most serious public health threats that require urgent and aggressive action. These study results are the first steps towards developing a new treatment for this major healthcare problem.